Angelo Antonini researcher
Antonini, Angelo
VIAF ID: 303285027 (Personal)
Permalink: http://viaf.org/viaf/303285027
Preferred Forms
- 100 0 _ ‡a Angelo Antonini ‡c researcher
-
-
- 100 1 _ ‡a Antonini, Angelo
- 100 1 _ ‡a Antonini, Angelo
4xx's: Alternate Name Forms (2)
Works
Title | Sources |
---|---|
[11C]raclopride and positron emission tomography in previously untreated patients with Parkinson's disease: Influence of L-dopa and lisuride therapy on striatal dopamine D2-receptors. | |
[11C]raclopride-PET studies of the Huntington's disease rate of progression: relevance of the trinucleotide repeat length | |
The "gender factor" in wearing-off among patients with Parkinson's disease: a post hoc analysis of DEEP study. | |
Handbook of non-motor symptoms in Parkinson's disease, 2011: | |
Imaging evidence supports a link between essential tremor and Parkinson's disease | |
The impact of COVID-19 on palliative care for people with Parkinson’s and response to future pandemics | |
Istruzione teorica sopra le manovre e l'evoluzioni di linea della truppa a cavallo. Traduzione dal francese, che fà seguito al ristretto della istruzione teorica sopra l'esercizio, e le manovre della truppa a cavallo dato alla luce in Roma nell'anno 1830 da S.E. il signor don Pompeo de' principi Gabrielli ... del cav. Angelo Antonini ... | |
The metabolic anatomy of Tourette's syndrome. | |
The metabolic topography of essential blepharospasm: a focal dystonia with general implications. | |
The MTHFR C677T polymorphism modifies age at onset in Parkinson's disease. | |
The neural correlates of spatial and object working memory in elderly and Parkinson's disease subjects. | |
A New MRI Measure to Early Differentiate Progressive Supranuclear Palsy From De Novo Parkinson's Disease in Clinical Practice: An International Study | |
An Observational Study of the Effect of Levodopa-Carbidopa Intestinal Gel on Activities of Daily Living and Quality of Life in Advanced Parkinson's Disease Patients | |
An overnight switch to ropinirole therapy in patients with Parkinson's disease. Short communication | |
The possible clinical predictors of fatigue in Parkinson's disease: a study of 135 patients as part of international nonmotor scale validation project | |
The PRIAMO study: active sexual life is associated with better motor and non-motor outcomes in men with early Parkinson's disease | |
The PRIAMO study: background, methods and recruitment. | |
The PRIAMO study: urinary dysfunction as a marker of disease progression in early Parkinson's disease. | |
A proposal for a comprehensive grading of Parkinson's disease severity combining motor and non-motor assessments: meeting an unmet need | |
The rationale for improved integration between home care and neurology hospital services in patients with advanced Parkinson's disease | |
Regression of cardiac valvulopathy related to ergot-derived dopamine agonists | |
Regulation of ER-mitochondria contacts by Parkin via Mfn2 | |
The relationship between impulsivity and impulse control disorders in Parkinson's disease | |
Relationship of Nocturnal Sleep Dysfunction and Pain Subtypes in Parkinson's Disease | |
Relevance of sleep quality on caregiver burden in Parkinson's disease. | |
Reply to: "Concerns Raised by Publication of Antonini et al., 'Outcome of Parkinson Disease Patients Affected by Covid-19'" | |
Reply to: "Parkinson disease-associated dyskinesia in countries with low access to levodopa-sparing Regimens" | |
Reproducibility of regional metabolic covariance patterns: comparison of four populations. | |
The role of high-field magnetic resonance imaging in parkinsonian disorders: Pushing the boundaries forward | |
The role of I-ioflupane SPECT dopamine transporter imaging in the diagnosis and treatment of patients with dementia with Lewy bodies. | |
Rotigotine transdermal patch in the management of Parkinson's disease (PD) and its night-time use for PD-related sleep disorders. | |
Selecting deep brain stimulation or infusion therapies in advanced Parkinson's disease: an evidence-based review | |
Should there be less emphasis on levodopa-induced dyskinesia in Parkinson's disease? | |
A signature pattern of cortical atrophy in dementia with Lewy bodies: A study on 333 patients from the European DLB consortium | |
Single-photon emission computed tomography in diagnosis and differential diagnosis of Parkinson's disease | |
Sleep in genetically confirmed pantothenate kinase-associated neurodegeneration: a video-polysomnographic study | |
Speech and Voice Response to a Levodopa Challenge in Late-Stage Parkinson's Disease | |
The status of dopamine nerve terminals in Parkinson's disease and essential tremor: a PET study with the tracer [11-C]FE-CIT. | |
The status of olfactory function and the striatal dopaminergic system in drug-induced parkinsonism. | |
Striatal dopamine transporter abnormalities in patients with essential tremor | |
Striatal dopamine transporter binding in Parkinson's disease associated with the LRRK2 Gly2019Ser mutation. | |
Striatal glucose metabolism and dopamine D2 receptor binding in asymptomatic gene carriers and patients with Huntington's disease | |
Stridor in multiple system atrophy: Consensus statement on diagnosis, prognosis, and treatment | |
Subthalamic Stimulation Improves Quality of Life of Patients Aged 61 Years or Older With Short Duration of Parkinson's Disease. | |
Surgical, medical, and hardware adverse events in a series of 141 patients undergoing subthalamic deep brain stimulation for Parkinson disease | |
Switching from constant voltage to constant current in deep brain stimulation: a multicenter experience of mixed implants for movement disorders | |
Tc-99m ethylene cysteinate dimer SPECT in the differential diagnosis of parkinsonism | |
tDCS effect on cognitive performance in Parkinson's disease | |
Temporal lobe epilepsy: correlation of proton magnetic resonance spectroscopy and 18F-fluorodeoxyglucose positron emission tomography. | |
Therapeutic strategies to prevent and manage dyskinesias in Parkinson's disease | |
Thin section MR study of the basal ganglia in the differential diagnosis between striatonigral degeneration and Parkinson disease. | |
Tolerability of paroxetine in Parkinson's disease: A prospective study | |
Treatment with D-penicillamine improves dopamine D2-receptor binding and T2-signal intensity in de novo Wilson's disease. | |
Tremor UPDRS estimation in home environment. | |
Understanding and Treating Pain Syndromes in Parkinson's Disease. | |
USP14 inhibition corrects an model of impaired mitophagy | |
Validation of a home environment test battery for supporting assessments in advanced Parkinson's disease. | |
Validation of the Italian version of the Movement Disorder Society--Unified Parkinson's Disease Rating Scale. | |
Validity and metric of MiniMental Parkinson and MiniMental State Examination in Parkinson's disease. | |
Valvular heart disease and the use of dopamine agonists for Parkinson's disease | |
Viewpoint and practical recommendations from a movement disorder specialist panel on objective measurement in the clinical management of Parkinson's disease. | |
Water-based vs. non-water-based physiotherapy for rehabilitation of postural deformities in Parkinson's disease: a randomized controlled pilot study. | |
Wearing-off scales in Parkinson's disease: critique and recommendations | |
What is the best treatment for fluctuating Parkinson's disease: continuous drug delivery or deep brain stimulation of the subthalamic nucleus? | |
Which patients discontinue? Issues on Levodopa/carbidopa intestinal gel treatment: Italian multicentre survey of 905 patients with long-term follow-up. | |
α-Synuclein multiplication analysis in Italian familial Parkinson disease |